NDC 70004-222

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 70004-222
Product root: 70004-222
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 18 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	70004-222	70004-222-30	COMPOUNDER	Outsourcing facility compounded drug report	2023-1	2026-10-15
compounder	package	70004-222	70004-222-30	COMPOUNDER	Outsourcing facility compounded drug report	2022-2	2026-10-15
compounder	package	70004-222	70004-222-30	COMPOUNDER	Outsourcing facility compounded drug report	2021-2	2026-10-15
compounder	package	70004-222	70004-222-09	COMPOUNDER	Outsourcing facility compounded drug report	2021-2	2026-10-15
compounder	package	70004-222	70004-222-09	COMPOUNDER	Outsourcing facility compounded drug report	2020-2	2026-10-15
compounder	package	70004-222	70004-222-04	COMPOUNDER	Outsourcing facility compounded drug report	2020-2	2026-10-15
compounder	package	70004-222	70004-222-30	COMPOUNDER	Outsourcing facility compounded drug report	2020-2	2026-10-15
compounder	package	70004-222	70004-222-30	COMPOUNDER	Outsourcing facility compounded drug report	2020-1	2026-10-15
compounder	package	70004-222	70004-222-09	COMPOUNDER	Outsourcing facility compounded drug report	2020-1	2026-10-15
compounder	package	70004-222	70004-222-04	COMPOUNDER	Outsourcing facility compounded drug report	2020-1	2026-10-15
compounder	package	70004-222	70004-222-04	COMPOUNDER	Outsourcing facility compounded drug report	2019-2	2026-10-15
compounder	package	70004-222	70004-222-09	COMPOUNDER	Outsourcing facility compounded drug report	2019-2	2026-10-15
compounder	package	70004-222	70004-222-30	COMPOUNDER	Outsourcing facility compounded drug report	2019-2	2026-10-15
compounder	package	70004-222	70004-222-23	COMPOUNDER	Outsourcing facility compounded drug report	2019-2	2026-10-15
compounder	package	70004-222	70004-222-04	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-15
compounder	package	70004-222	70004-222-23	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-15
compounder	package	70004-222	70004-222-09	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-15
compounder	package	70004-222	70004-222-30	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 22 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Reporting period table
Captured / source date	Package NDC	Reporting period	Snapshot	Source SHA-256
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-30	2023-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-30	2022-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-30	2021-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-09	2021-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-04	2020-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-09	2020-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-30	2020-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-04	2020-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-09	2020-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-30	2020-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-09	2019-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-30	2019-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-23	2019-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-04	2019-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-04	2019-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-30	2019-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-09	2019-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	70004-222-23	2019-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-01-13 04:20 UTC · source 2024-11-20	70004-222-30	2023-1	`85f958c8d153…`	`997044a9741e…`
2025-01-13 04:20 UTC · source 2024-11-20	70004-222-30	2022-2	`85f958c8d153…`	`997044a9741e…`
2022-05-13 07:20 UTC · source 2022-04-19	70004-222-30	2021-2	`4694734df12d…`	`db2bf3a0aaab…`
2022-05-13 07:20 UTC · source 2022-04-19	70004-222-09	2021-2	`4694734df12d…`	`db2bf3a0aaab…`

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-30	Fentanyl Citrate	.05 mg/1 mL	2023-1	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-30	Fentanyl Citrate	.05 mg/1 mL	2022-2	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-09	Fentanyl Citrate	.05 mg/1 mL	2021-2	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-30	Fentanyl Citrate	.05 mg/1 mL	2021-2	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-04	Fentanyl Citrate	.05 mg/1 mL	2020-2	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-09	Fentanyl Citrate	.05 mg/1 mL	2020-2	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-30	Fentanyl Citrate	.05 mg/1 mL	2020-2	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-04	Fentanyl Citrate	.05 mg/1 mL	2020-1	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-09	Fentanyl Citrate	.05 mg/1 mL	2020-1	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-30	Fentanyl Citrate	.05 mg/1 mL	2020-1	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-04	Fentanyl Citrate	.05 mg/1 mL	2019-2	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-09	Fentanyl Citrate	.05 mg/1 mL	2019-2	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-23	Fentanyl Citrate	.05 mg/1 mL	2019-2	valid
"SCA Pharmaceuticals, LLC(080545245)"	70004-222	70004-222-30	Fentanyl Citrate	.05 mg/1 mL	2019-2	valid
"SCA Pharmaceuticals, LLC(037559301)"	70004-222	70004-222-04	Fentanyl Citrate	.05 mg/1 mL	2019-1	valid
"SCA Pharmaceuticals, LLC(037559301)"	70004-222	70004-222-09	Fentanyl Citrate	.05 mg/1 mL	2019-1	valid
"SCA Pharmaceuticals, LLC(037559301)"	70004-222	70004-222-23	Fentanyl Citrate	.05 mg/1 mL	2019-1	valid
"SCA Pharmaceuticals, LLC(037559301)"	70004-222	70004-222-30	Fentanyl Citrate	.05 mg/1 mL	2019-1	valid

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.